Literature DB >> 32712328

Heart team 2.0: A decision tree for minimally invasive and hybrid myocardial revascularization.

Jef Van den Eynde1, Johan Bennett2, Keir McCutcheon3, Tom Adriaenssens2, Walter Desmet2, Christophe Dubois2, Peter Sinnaeve2, Tom Verbelen1, Steven Jacobs1, Wouter Oosterlinck4.   

Abstract

Recent years have seen an important shift in the target population for myocardial revascularization. Patients are increasingly presenting with more complex coronary artery disease (CAD), but also with multiple comorbidities and frailty. At the same time, minimally invasive strategies such as Minimally Invasive Direct Coronary Artery Bypass Grafting (MIDCAB) and Percutaneous Coronary Interventions (PCI) have been developed, which might be more appealing for this group of patients. As a result, the landscape of options for myocardial revascularization is evolving while adequate use of all resources is required to ensure optimal patient care. Heart Teams are confronted with the challenge of incorporating the new minimally invasive strategies into the decision process, yet current guidelines do not fully address this challenge. In this review, the current evidence regarding outcomes, indications, benefits, and risks of off-pump coronary artery bypass grafting (OPCAB), MIDCAB, PCI, and hybrid coronary revascularization (HCR) are discussed. Based on this evidence and on experiences from Heart Team discussions, a new decision tree is proposed that incorporates recent advances in minimally invasive revascularization strategies, thereby optimizing adequate delivery of care for each individual patient's needs. Introducing all important considerations in a logical way, this tool facilitates the decision-making process and might ensure appropriate use of resources and optimal care for individual patients.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Coronary artery bypass grafting; Coronary artery disease; Hybrid coronary revascularization; Minimally invasive; Myocardial revascularization; Percutaneous coronary intervention

Year:  2020        PMID: 32712328     DOI: 10.1016/j.tcm.2020.07.005

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  5 in total

1.  Safe implementation of robotic-assisted minimally invasive direct coronary artery bypass: application of learning curves and cumulative sum analysis.

Authors:  Jef Van den Eynde; Hannah Vaesen Bentein; Tom Decaluwé; Herbert De Praetere; MaryAnn C Wertan; Francis P Sutter; Husam H Balkhy; Wouter Oosterlinck
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

Review 2.  Hybrid coronary revascularization versus percutaneous coronary intervention: A systematic review and meta-analysis.

Authors:  Jef Van den Eynde; Michel Pompeu Sá; Senne De Groote; Andrea Amabile; Serge Sicouri; Basel Ramlawi; Gianluca Torregrossa; Wouter Oosterlinck
Journal:  Int J Cardiol Heart Vasc       Date:  2021-12-01

3.  A Classification Tree Model with Optical Coherence Tomography Angiography Variables to Screen Early-Stage Diabetic Retinopathy in Diabetic Patients.

Authors:  Hongyan Yao; Shanjun Wu; Zongyi Zhan; Zijing Li
Journal:  J Ophthalmol       Date:  2022-02-15       Impact factor: 1.909

4.  Revascularization strategies in patients with multivessel coronary artery disease: a Bayesian network meta-analysis.

Authors:  Jef Van den Eynde; Katrien Bomhals; Dries Noé; Xander Jacquemyn; Keir McCutcheon; Johan Bennett; John D Puskas; Wouter Oosterlinck
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

Review 5.  Minimally Invasive Coronary Revascularisation Surgery: A Focused Review of the Available Literature.

Authors:  Karel M Van Praet; Markus Kofler; Timo Z Nazari Shafti; Alaa Abd El Al; Antonia van Kampen; Andrea Amabile; Gianluca Torregrossa; Jörg Kempfert; Volkmar Falk; Husam H Balkhy; Stephan Jacobs
Journal:  Interv Cardiol       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.